Atelerix Seed
4 known investors
Find your way into Atelerix Seed
169 people in our graph share verified history with the Atelerix Seed team — schools, employers, funds. One of them is your warm intro.
Anmol Goelunlockedknows Steve Swioklo · together at University of Liverpool
×6knows the team · via University of Reading
×5knows the team · via University of Liverpool
Atelerix develops hypothermic hydrogel encapsulation technology that stabilises and preserves fresh cells, tissues, and blood at room temperature, eliminating the need for cryopreservation and cold-chain logistics. Its plant-based, xeno-free kits (such as CytoStor, BeadReady, and STORganoid) serve research and clinical labs shipping live cell material, organoids, and 3D cell models.
Founders & leadership
SS
Steve SwiokloinFounder · Chief Scientific OfficerSteve Swioklo holds a PhD from the University of Reading and conducted postdoctoral research at Newcastle University on hydrogel encapsulation of cells and tissues for room temperature preservation. He is co-founder and CSO of Atelerix, which develops cell preservation technologies for research and clinical applications.
Investors · 4
Frequently asked questions
- What does Atelerix Seed do?
- Atelerix develops hypothermic hydrogel encapsulation technology that stabilises and preserves fresh cells, tissues, and blood at room temperature, eliminating the need for cryopreservation and cold-chain logistics. Its plant-based, xeno-free kits (such as CytoStor, BeadReady, and STORganoid) serve research and clinical labs shipping live cell material, organoids, and 3D cell models.
- Who founded Atelerix Seed?
- Atelerix Seed was founded by Steve Swioklo.
- Who are Atelerix Seed's investors?
- Atelerix Seed's investors include Cambridge Angels group, Future Planet Capital, O2h Ventures, UK Innovation & Science Seed Fund.